Skip to main content
SpringerLink
Log in

What we do when we suppress fever

  • Invited Commentary
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Oldach DW, Richard R, Borza EN, Benitez RM: A mysterious death. N Engl J Med 1998, 338:1764–1769.

    Article  PubMed  CAS  Google Scholar 

  2. O’Donnell J, Axelrod P, Fisher C, Lorber B: Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit. Clin Infect Dis 1997, 24:1208–1213.

    PubMed  CAS  Google Scholar 

  3. Jack DB: One hundred years of aspirin. Lancet 1997, 350:437–439.

    Article  PubMed  CAS  Google Scholar 

  4. Mann J: Murder, Magic, and Medicine. Oxford: Oxford University Press; 1992.

    Google Scholar 

  5. Vane JR, Flower RJ, Botting RM: History of aspirin and its mechanisms of action. Stroke 1990, 21(Suppl 4):IV12-IV23.

    PubMed  CAS  Google Scholar 

  6. Kluger MJ, Kozak W, Conn CA, et al.: The adaptive value of fever. In Fever: Basic Mechanisms and Management, edn 2. Edited by Mackowiak PA. Philadelphia: Lippincott-Raven; 1997:255–266.

    Google Scholar 

  7. Mackowiak PA: Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 1994, 120:1037–1040.

    PubMed  CAS  Google Scholar 

  8. Mackowiak PA: Temperature regulation and the pathogenesis of fever. In Principles and Practice of Infectious Diseases, edn 5. Edited by Mandell GL, Douglas RG, Bennett JE. Philadelphia: Churchill Livingstone; 2000:604–622.

    Google Scholar 

  9. Kluger MJ, Ringler DH, Anver MR: Fever and survival. Science 1975, 188:166–168.

    Article  PubMed  CAS  Google Scholar 

  10. Bernheim HA, Klugher MJ: Fever: effect of drug-induced antipyresis on survival. Science 1976, 193:237–239.

    Article  PubMed  CAS  Google Scholar 

  11. Covert JR, Reynolds WW: Survival value of fever in fish. Nature 1977, 267:43–45.

    Article  PubMed  CAS  Google Scholar 

  12. Greisman SE: Cardiovascular alterations during fever. In Fever: Basic Mechanisms and Management. Edited by Mackowiak PA. New York: Raven Press; 1991:143–165.

    Google Scholar 

  13. Bryant RE, Hood AF, Hood CE, Koenig MG: Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1971, 127:120–128.

    Article  PubMed  CAS  Google Scholar 

  14. Mackowiak PA, Browne RH, Southern PM Jr, Smith JW: Polymicrobial sepsis analysis of 184 cases using log linear models. Am J Med Sci 1980, 280:73–80.

    Article  PubMed  CAS  Google Scholar 

  15. Weinstein MR, Iannini PB, Staton CW, Eichoff TC: Spontaneous bacterial peritonitis; a review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978, 64:592–598.

    Article  PubMed  CAS  Google Scholar 

  16. Dorn TF, DeAngelis C, Baumgardner RA, et al.: Acetaminophen: more harm than good for chicken pox? J Pediatr 1989, 114:1045–1048.

    Article  Google Scholar 

  17. Stanley ED, Jackson GG, Panusarn C, et al.: Increased viral shedding with aspirin treatment of rhinovirus infection. JAMA 1975, 231:1248–1251.

    Article  PubMed  CAS  Google Scholar 

  18. Graham MH, Burrell CJ, Douglas RM, et al.: Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990, 162:1277–1282.

    PubMed  CAS  Google Scholar 

  19. Plaisance KI, Kudaravalli S, Wasserman SS, et al.: Effect of antipyretic therapy on duration of illness in experimental influenza A, Shigella sonnei and Rickettsia rickettsii infections. Pharmacotherapy 2000, 20:1417–1422.

    Article  PubMed  CAS  Google Scholar 

  20. Dinarello CA: Endogenous pyrogens. The role of cytokines in the pathogenesis of fever. In Fever: Basic Mechanisms and Management. Edited by Mackowiak PA. New York: Raven Press; 1991:23–47.

    Google Scholar 

  21. Bernheim HA, Bodel T, Askenase PW, Atkins E: Effects of fever on host defense mechanisms after injection of the lizard Dipsosaurus dorsalis. Br J Exp Pathol 1978, 59:76–84.

    PubMed  CAS  Google Scholar 

  22. Dinarello CA: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991, 163:1177–1184.

    PubMed  CAS  Google Scholar 

  23. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771–778.

    PubMed  CAS  Google Scholar 

  24. Mira JP, Cariou A, Grall F, et al.: Association of TNF 2, a TNF [alpha] promoter polymorphism, with septic shock susceptibility: a multicenter study. JAMA 1999, 282:561–568.

    Article  PubMed  CAS  Google Scholar 

  25. Johnson J, Brigman KL, Jesmok G, Meyrick B: Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor á. Am Rev Respir Dis 1991, 144:179–186.

    PubMed  CAS  Google Scholar 

  26. Heinzel FP: The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990, 145:2920–2924.

    PubMed  CAS  Google Scholar 

  27. Henricson BE, Neta R, Vogel SN: An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun 1991, 59:1188–1191.

    PubMed  CAS  Google Scholar 

  28. Ohlsson K, Björk P, Bergenfeldt M, et al.: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990, 348:550–552.

    Article  PubMed  CAS  Google Scholar 

  29. Opal SM, Cross AS, Sadoff JC, et al.: Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis. J Clin Invest 1991, 88:885–890.

    PubMed  CAS  Google Scholar 

  30. Overbeek BP, Veringa EM: Role of antibodies and antibiotics in aerobic gram-negative septicemia: possible synergism between antimicrobial treatment and immunotherapy. Rev Infect Dis 1991, 13:751–760.

    PubMed  CAS  Google Scholar 

  31. Alexander HR, Sheppard BC, Jensen JC, et al.: Treatment with recombinant tumor necrosis factor-alpha protects rats against lethality, hypotension, and hypothermia of gramnegative sepsis. J Clin Invest 1991, 88:34–39.

    PubMed  CAS  Google Scholar 

  32. Fisher CJ Jr, Agosti JM, Opal SM, et al.: Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996, 334:1697–1702.

    Article  PubMed  CAS  Google Scholar 

  33. Mackowiak PA, Boulant JA: Fever’s glass ceiling. Clin Infect Dis 1996, 22:525–536.

    PubMed  CAS  Google Scholar 

  34. Hirtz DG: Generalized tonic clonic and febrile seizures. Pediatr Clin North Am 1989, 36:365–382.

    PubMed  CAS  Google Scholar 

  35. Berg AT: Febrile seizures and epilepsy: the contributions of epidemiology. Paediatr Perinat Epidemiol 1992, 6:145–152.

    Article  PubMed  CAS  Google Scholar 

  36. Lessell S, Torres JM, Kurland LT: Seizure disorders in a Guamanian village. Arch Neurol 1962, 7:37–44.

    PubMed  CAS  Google Scholar 

  37. Aicardi J: Febrile convulsions. In Epilepsy in Children, edn 2. Edited by Aicardi J. New York: Raven Press; 1994:253–275.

    Google Scholar 

  38. Lennox-Buchthal MA: Febrile Convulsions: A Reappraisal. Amsterdam: Elsevier; 1973.

    Google Scholar 

  39. Rosman NP: Febrile convulsions. In Fever: Basic Mechanisms and Management, edn 2. Edited by Mackowiak PA. Philadelphia: Lippincott-Raven; 1997:267–277.

    Google Scholar 

  40. Styrt B, Sugarman B: Antipyresis and fever. Arch Intern Med 1990, 150:1589–1597.

    Article  PubMed  CAS  Google Scholar 

  41. Horwath SM, Spurr GB, Hutt BK, Hamilton LH: Metabolic cost of shivering. J Appl Physiol 1956, 8:595–602.

    Google Scholar 

  42. Mackowiak PA, Plaisance KI: The benefits and risks of antipyretic therapy. Ann N Y Acad Sci 1998, 856:214–223.

    Article  PubMed  CAS  Google Scholar 

  43. Beisel WR, Morgan BB Jr, Bartelloni PJ, et al.: Symptomatic therapy in viral illness. A controlled study of effects on work performance. JAMA 1974, 228:581–584.

    Article  PubMed  CAS  Google Scholar 

  44. Plaisance KI, Mackowiak PA: Antipyretic therapy. Physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med 2000, 160:949–956.

    Article  Google Scholar 

  45. Manthores CA, Hall JB, Olson D, et al.: Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 1995, 151:10–14.

    Google Scholar 

  46. Raizner AE, Chahine RA, Ishimori T, et al.: Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative arteriographic observations. Circulation 1980, 62:925–932.

    PubMed  CAS  Google Scholar 

  47. Friedman PL, Brown EJ Jr, Gunther S, et al.: Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. N Engl J Med 1981, 305:1171–1175.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Service-111, VA Medical Center, 10 North Greene Street, 21201, Baltimore, MD, USA

    Philip A. Mackowiak MD

Authors
  1. Philip A. Mackowiak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mackowiak, P.A. What we do when we suppress fever. Curr Infect Dis Rep 7, 1–4 (2005). https://doi.org/10.1007/s11908-005-0016-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-005-0016-y

Keywords

Search

Navigation